Voyager Therapeutics Inc (VYGR)
5.44
+0.08
(+1.49%)
USD |
NASDAQ |
Nov 21, 14:49
Voyager Therapeutics Price: 5.44 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 5.41 | 5.59 | 5.28 | 5.36 | 464359.0 |
Nov 19, 2024 | 5.37 | 5.375 | 5.193 | 5.27 | 703896.0 |
Nov 18, 2024 | 5.65 | 5.65 | 5.38 | 5.385 | 573354.0 |
Nov 15, 2024 | 6.11 | 6.150 | 5.590 | 5.64 | 795871.0 |
Nov 14, 2024 | 6.73 | 6.775 | 6.18 | 6.22 | 710785.0 |
Nov 13, 2024 | 7.02 | 7.38 | 6.654 | 6.69 | 698275.0 |
Nov 12, 2024 | 7.04 | 7.051 | 6.740 | 6.83 | 556963.0 |
Nov 11, 2024 | 7.26 | 7.43 | 6.97 | 7.01 | 515934.0 |
Nov 08, 2024 | 7.08 | 7.20 | 6.94 | 7.13 | 365871.0 |
Nov 07, 2024 | 7.28 | 7.39 | 7.04 | 7.10 | 459810.0 |
Nov 06, 2024 | 6.99 | 7.34 | 6.83 | 7.28 | 762912.0 |
Nov 05, 2024 | 6.54 | 6.69 | 6.401 | 6.65 | 487377.0 |
Nov 04, 2024 | 7.18 | 7.23 | 6.64 | 6.65 | 718854.0 |
Nov 01, 2024 | 6.81 | 7.10 | 6.62 | 7.00 | 1.200M |
Oct 31, 2024 | 6.83 | 6.95 | 6.61 | 6.83 | 683020.0 |
Oct 30, 2024 | 7.05 | 7.203 | 6.83 | 6.84 | 301845.0 |
Oct 29, 2024 | 6.95 | 7.26 | 6.894 | 7.07 | 433771.0 |
Oct 28, 2024 | 6.84 | 7.36 | 6.84 | 7.02 | 531679.0 |
Oct 25, 2024 | 6.61 | 6.886 | 6.52 | 6.75 | 469263.0 |
Oct 24, 2024 | 6.44 | 6.77 | 6.42 | 6.575 | 558161.0 |
Oct 23, 2024 | 6.21 | 6.44 | 6.105 | 6.43 | 700728.0 |
Oct 22, 2024 | 6.93 | 7.00 | 6.10 | 6.19 | 2.479M |
Oct 21, 2024 | 8.11 | 8.17 | 7.599 | 7.66 | 465699.0 |
Oct 18, 2024 | 8.04 | 8.275 | 7.98 | 8.07 | 413964.0 |
Oct 17, 2024 | 7.92 | 8.089 | 7.70 | 8.01 | 572251.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.47
Minimum
Oct 05 2021
14.98
Maximum
Dec 24 2019
7.711
Average
7.55
Median
Jan 29 2021
Price Benchmarks
Rhythm Pharmaceuticals Inc | 59.43 |
NovaBay Pharmaceuticals Inc | 0.70 |
Palatin Technologies Inc | 0.9146 |
iBio Inc | 2.39 |
Theriva Biologics Inc | 1.24 |
Price Related Metrics
PE Ratio | 8.369 |
PS Ratio | 1.853 |
Price to Book Value | 0.8996 |
Earnings Yield | 11.95% |
Market Cap | 297.16M |
Operating PE Ratio | 33.44 |
Normalized PE Ratio | 8.369 |